The Trump administration has announced plans to convert government grant funds intended for Intel into a 10% equity stake in the company, raising questions about both legality and effectiveness. Intel’s foundry business, which manufactures chips for external clients, reported a $3.1 billion loss last quarter and continues to face layoffs and missed contracts.
Related: Intel Confirms $8.9B Equity Deal With Trump Administration Amid CHIPS Act Controversy
Critics warn the equity deal dilutes shareholder value and does little to solve Intel’s core problem, poor customer engagement and lagging competitiveness. Supporters argue the move signals strong government backing for Intel’s role in U.S. chipmaking and could boost investor confidence. Analysts, however, caution that Intel’s real challenge will be attracting demand for its upcoming 14A chipmaking process, not government intervention.
